i b l e t o 200 vg; one t o nine t r e a tment courses were required t o reach 200 wg. Anaphylactic react i o n s were experienced by 11/18 p a t i e n t s during i n j e c t i o n therapy. P a t i e n t s then returned f o r d e l i b e r a t e honeybee s t i n g challenges. I n i t i a l s t i n g challenges were t o l e r a t e d well by 10117 p a t i e n t s completing therapy; 7 o t h e r p a t i e n t s required epinephr i n e . With subsequent treatment 11/17 p a t i e n t s achieved complete c l i n i c a l p r o t e c t i o n ; p a r t i a l p r o t e c t i o n was achieved by 3 o t h e r s . P r o t e c t i o n was maintained by p e r i o d i c d e l i b e r a t e s t i n g s o r by HBV i n j e c t i o n s a t 2-8 week i n t e r v a l s . Serum IgE a n t i b o d i e s t o HBV and t o venom phospholipase-A (PLA) r o s e d r a m a t i c a l l y (%-350%) a ft e r therapy and remained elevated over b a s e l i n e l e v e l s i n 14 pat i e n t s . Serum IgG a n t i b o d i e s t o PLA r o s e s t e a d i l y during therapy and approximated those seen i n hyperimmune beekeepers i n 8 pat i e n t s . There was no l e v e l of IgG antibody which was p r o t e c t i v e f o r a l l p a t i e n t s . . The r e s u l t s i n d i c a t e t h a t under c o n t r o l l e d cond i t i o n s HBV immunotherapy provides c l i n i c a l p r o t e c t i o n i n t h e maj o r i t y of p a t i e n t s .
J . Gleich (Spon. by G . S. G i l c h r i s t ) . Depts. of Ped.. I n t . Med., and Immunol.. Mayo C l i n i c and Foundation. Rochester.MN. Preliminary s t u d i e s have suggested t h a t venom irm~unotherapy f o r Hymenoptera-sensitive persons may be s u p e r i o r t o conventional inmunotherapy with whole i n s e c t e x t r a c t s . The immunological and c l i n i c a l e f f e c t s of honeybee venom (HBV) "rush" h y p o s e n s i t i z a t i o n were t e s t e d i n 18 p a t i e n t s , who received an i n t e n s i v e two-day course of HBV i n j e c t i o n s once monthly.
I n i t i a l doses of 0.5 pg were r a i s e d a s r a p i d l y a s p o s s i b l e t o 200 vg; one t o nine t r e a tment courses were required t o reach 200 wg. Anaphylactic react i o n s were experienced by 11/18 p a t i e n t s during i n j e c t i o n therapy. P a t i e n t s then returned f o r d e l i b e r a t e honeybee s t i n g challenges. I n i t i a l s t i n g challenges were t o l e r a t e d well by 10117 p a t i e n t s completing therapy; 7 o t h e r p a t i e n t s required epinephr i n e . With subsequent treatment 11/17 p a t i e n t s achieved complete c l i n i c a l p r o t e c t i o n ; p a r t i a l p r o t e c t i o n was achieved by 3 o t h e r s . P r o t e c t i o n was maintained by p e r i o d i c d e l i b e r a t e s t i n g s o r by HBV i n j e c t i o n s a t 2-8 week i n t e r v a l s . Serum IgE a n t i b o d i e s t o HBV and t o venom phospholipase-A (PLA) r o s e d r a m a t i c a l l y (%-350%) a ft e r therapy and remained elevated over b a s e l i n e l e v e l s i n 14 pat i e n t s . Serum IgG a n t i b o d i e s t o PLA r o s e s t e a d i l y during therapy and approximated those seen i n hyperimmune beekeepers i n 8 pat i e n t s . There was no l e v e l of IgG antibody which was p r o t e c t i v e f o r a l l p a t i e n t s . . The r e s u l t s i n d i c a t e t h a t under c o n t r o l l e d cond i t i o n s HBV immunotherapy provides c l i n i c a l p r o t e c t i o n i n t h e maj o r i t y of p a t i e n t s . The 48 p t s with WBC< 20.000/mm3 (L*2O%, BL<80%. T 29t5X) had normal DRCs and TRCs. The maximal response was achieved on day 4 (78.500f5.800 cpm). A l l p t s had Null c e l l leukemia; 7/48 (14%) p t s have relapsed i n t h e marrow (BM) . The remaining 22 p t s with WB~>20.000/mm~ (L< 20%. BL>80X. T 17.524%) a l l responded abnormelly.
13/22 p t a had a d e f i n i t e but decreased response on day 4 (18,84625,400 cpm) w i t h a 2-t o 4-fold g r e a t e r response on day 6 (WBC 100.000 2 8,000. : L 9.123. XBL 88t8. XT 7.323). A l l p t s had Null c e l l leukemia; 4/13 (30%) have relapsed i n t h e BM. The remeining 9 p t s were unresponsive t o PHA on day 4 and f a i l e d t o show a delayed peak on day 6 (224.000f10.500, % L 4.3f2. XBL 932 7. X T 39t9). 419 p t s had T-cell leukemia; 619(66%) have r e l a p s e d i n t h e BM. Three response p a t t e r n s t o PHA were found i n p t s with ALL: (a) normal ( To determine t h e prognostic s i g n i f i c a n c e of leukopenia i n e a r l y o n s e t n e o n a t a l group B s t r e p t o c o c c a l s e p s i s . Nursery ICU admissions were reviewed from [1969] [1970] [1971] [1972] [1973] [1974] [1975] [1976] . 40 c a s e s of blood c u l t u r e proven Group B s t r e p t o c o c c a l s e p s i s were found i n i n f a n t s under 5 days of age. 55% were premature i n f a n t s . The m a j o r i t y of p a t i e n t s (78%) presented w i t h r e s p i r a t o r y d i s t r e s s o f t e n a s s o c i a t e d with apnea. Leukopenis ( t o t a l WBC < 5000) was found i n 48% of t h e s e p t i c i n f a n t a . Of 21 p a t i e n t s who had lumbar punctures, 12 had Group B s t r e p t o c o c c u s i s o l a t e d from t h e CSF a s w e l l a s blood.
The o v e r a l l s u r v i v a l of combined term and preterm i n f a n t s was 70%. Term i n f a n t s showed no c o r r e l a t i o n between leukopenia and s u r v i v a l (83% (10/12) of i n f a n t s w i t h normal lWBC survived versus 83% (516) f o r i n f a n t s with TWBC < 5000). I n premature i n f a n t s leukopenia seemed t o be a s s o c i a t e d w i t h a decreased s u r v i v a l (78% (719) of i n f a n t s with normal TWBC survived v e r s u s 46% (6113) of i n f a n t s w i t h TWBC < 5000). however, t h i s d i f f e r e n c e was found t o be i n s i g n i f i c a n t (p-0.15 by t h e F i s h e r Exact T e s t ) .
Currently more c a s e s a r e being sought t o determine i f t h e trend of decreased s u r v i v a l i n leukopenic prematures p e r s i s t s b u t , a t t h i s time. i t would appear t h a t t h e r e i s no s i g n i f i c a n t cor;elation between t h e l e v e l -b f TUBC and s u r v i v a l i n e a r l y o n s e t neonatal group 8 s t r e p t o c c a l s e p s i s .
, , , THE EFFECT OF 3 CORD CARE REGIMENS O N BACTERIAL COL-7 5 4 ONIZATION OF NORMAL NEONATES. Fred F. B a r r e t t , 
. --
One hundred i n f a n i s were randomly assigned t o each of t h r e e treatclent groups. A l l i n f a n t s received a c a s t i l e soap (CS) b a t h a t 6 h r s of age followed by no f u r t h e r cord c a r e i n t h e c o n t r o l group and e i t h e r a s i n g l e a p p l i c a t i o n of s i l v e r S u l f a d i a z i n e (SS) o r t r i p l e dye (TD) i n t h e 2 s t u d y groups. Semiquantitative umbilical and nasopharyngeal c u l t u r e s were obtained a t 48 h r s of age. SS s i g n i f i c a n t l y reduced umbilical group B s t r e p t o c o c c a l c o l o n i z a t i o n a t 48 h r s (27X) a s compared t o CS (40%) and TD (40%) . SS a l s o s i g n i i i c a n t l y reduced umbilical gram n e g a t i v e rod c o l o n i z a t i o n (52%) a s compared t o CS (90%) and TD (90%). TD was more e f f e c t i v e i n reducing Staph. aureus c o l o n i z a t i o n (15%) than SS (54%) b u t both were more e f f e c z h a n CS (72%). S t a h.
e. c o l o n i z a t i o n was s i g n i f i c a n t l y higher i n t h e SS sroup*) than i n t h e TD and CS groups (48% and 41% r e s p e c t i v e l y ) . There were no s i g n i f i c a n t d i f f e r e n c e s i n group D s t r e p t o c o c c a l colonization. No adverse r e a c t i o n s o r s i g n i f i c a n t s i d e e f f e c t s were encountered i n t h e atudy population.
CHRONIC EOSINOPHILIC MENINGITIS DUB TO LYMPHOCYTIC 7 5 5 CHORIOMENINGITIS VIRUS (LCMV) . P. Joan Chesney , Murray L. Katcher. Donald B. Nelson, Sheldon D. Horowitz ( I n t r . by R u s s e l l W. Chesney).
Univ. of Wisconsin Sch. of Med., Children's Hosp.. Dept. Ped.. and S t a t e Lab Hyg.. Madi s o n , Wisconsin.
LCMV i n f e c t i o n of a d u l t mice i s t h e c l a a a i c example of a n immunopathologic d i s e a s e , i n t h a t t h e c e l l mediated illarmne response of t h e host causes t h e d i s e a s e .
W e have seen a 2 112-year-old female w i t h chronic m e n i n g i t i s of 80 days' d u r a t i o n manifested by f a t i g u e , l e t h a r g y , CSF pleoc y t o s i s and high s p i k i n g f e v e r s . A p e r i p h e r a l e o s i n o p h i l i a (1,472-2.688 cellslmm3) and CSP e o s i n o p h i l i a (3-25%) were found during a one-month h o s p i t a l i z a t i o n a t t h e h e i g h t of h e r i l l n e s s .
Fourfold r i s e s i n CF. Neut. and Fluorescent antibody t i t e r s est a b l i s h e d LCMV a s t h e cause. Extensive e v a l u a t i o n s f o r paras i t i c o r o t h e r CNS o r systemic d i s e a s e were unrevealing.
T 6 B c e l l f u n c t i o n and macrophage s t u d i e s were normal during her i l l n e s s . During a documented i n t e r c u r r e n t i n f l u e n z a A/ V i c t o r i a i n f e c t i o n t h e following v a l u e s were found:
2/26/76 3/5/76 T o t a l Lymphocyte Count 2,639/mm3 4,182/mm3 T Cells: T o t a l E r o s e t t e s 264/mm3 1.924/mm3 (590-3090/mm3) Active E r o s e t t e s 0 l m 3 1.004/m3 Celf;T25/mm3) 343/ap3 6271mm3
Thia is t h e f i r s t known r e p o r t of prolonged f e v e r , eosinop h i l i a and chronic e o s i n o p h i l i c m e n i n g i t i s due t o LCMV. Karrsas. The p r o t e c t i v e r o l e o f maternally t r a n s f e r r e d a n t i b o d i e s on r e s i s t a n c e t o H. hominis i n f e c t i o n was examined by epidemiologic survey of 211 human s e r a f o r a n t i b o d i e s and by experimental i n f e c t i o n i n newborn mice. Twenty f i v e cord blood and 186 s e r a from persons of varyitrg ages were t e s t e d f o r a n t i b o d i e s a g a i n s t H . hominis by i n d i r e c t imnunofl u o r e s c e r~t s t a i n i n g method. The antibody reached t h e h i g h e s t l e v e l s i n the cord blood (mean titers = 1:1477) a11d the iowest l e v e l s between 6 months and one y e a r of age (mean titers= 1:156). The antibody approached the a d u l t l e v e l s (mean t i t e r s = 1:1193) by the age of 17 y e a r s . The apparent i n v e r s e r e l a t i o ns h i p between the antibody l e v e l s i n t h e population and t h e incidence of t h e d i s e a s e i n d i r e c t l y suggests t h e p r o t e c t i v e r o l e o f t h e a n t i b o d i e s .
MODULATION OF HERPESVIRUS HOMINIS
Exogenous a d m i n i s t r a t i o n of a n t i b o d i e s d i r e c t e d a g a i n s t H.
hominis t o pregnant mice r e s u l t e d i n an enhanced resist'atrce t o H. hominis i n f e c t i o n i n t h e o f f s p r i n g s . The m o r t a l i t y was 759 f o r t h e c o n t r o l s (35 mice) and 15% ( P 4 0 . 0 0 5 ) f o r t h e o f f s p r i n g s (39 mice) o f mothers r e c e i v i n g a n t i b o d i e s .
These d a t a suggest t h a t maternally t r a n s f e r r e d a n t i b o d i e s play a s i g n i f i c a n t r o l e i n modulating t h e pathogenesis of H .
hominis i n f e c t i o n i n t h e newborn.
